The Determine Antenatal Care Panel is used for the simultaneous detection of infectious diseases that threaten maternal and pediatric health.

The partnership will initially focus on low-abundance biomarkers supporting translational research in Alzheimer's disease.

NEW YORK – QuidelOrtho announced Monday an integration deal making fecal biomarker testing from Bühlmann Laboratories available on QuidelOrtho's Vitros system. The Bühlmann fecal tests detect ...

The company's next-generation sequencing-based test is used to aid the detection of cancers in patients with indeterminate ...

Last week, readers were most interested in a story about an extended collaboration between Personalis and Tempus to include colorectal cancer.

NEW YORK – Supported by a recent $4 million seed round, Chicago-based startup company OrisDx is preparing to bring to market this year a saliva-based test to aid the detection of oral cancers in ...

Oncologists were one of the few provider groups to register support for the FDA rule, reflecting the challenge of assessing ...

The companies have partnered with the goal of streamlining point-of-care access to Guardant's genomic cancer test portfolio.

The UK government said that it plans this year to repeal regulations specific to COVID-19 tests as part of the alignment with EU Common Specifications.